Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine GCSF vs HCG in ICSI
NCT04606082Unknown
- Sponsor
- Al-Azhar University
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Modality
- Cytokines & Interferons
01
Overview
Randomised, open-label trial of filgrastim in Recurrent Implantation Failure (RIF) (2 arms), sponsored by Al-Azhar University. Primary endpoint: Clinical Pregnancy Rate at 14 days. Status: unknown.
02
Drugs
filgrastim
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT04606082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04606082.